Kali Valuation
| KALY Stock | USD 0.0001 0.00 0.00% |
Kali seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Kali Inc from analyzing the firm fundamentals such as Return On Equity of 0.33, profit margin of 0.20 %, and Current Valuation of 814.59 K as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Kali's price fluctuation is very steady at this time. Calculation of the real value of Kali Inc is based on 3 months time horizon. Increasing Kali's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Kali is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kali Stock. However, Kali's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of Kali's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Kali's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Kali Inc helps investors to forecast how Kali stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kali more accurately as focusing exclusively on Kali's fundamentals will not take into account other important factors: Kali Total Value Analysis
Kali Inc is now expected to have valuation of 814.59 K with market capitalization of 814.59 K, debt of 401.3 K, and cash on hands of 29.97 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Kali fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
814.59 K | 814.59 K | 401.3 K | 29.97 M |
Kali Investor Information
The company has price-to-book ratio of 0.04. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Kali Inc had not issued any dividends in recent years. The entity had 1:3 split on the 24th of September 2012. Kali Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Kali Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Kali has an asset utilization ratio of 84.14 percent. This suggests that the Company is making $0.84 for each dollar of assets. An increasing asset utilization means that Kali Inc is more efficient with each dollar of assets it utilizes for everyday operations.Kali Profitability Analysis
The company reported the previous year's revenue of 71.54 K. Net Income was 1.35 K with profit before overhead, payroll, taxes, and interest of 42.06 M.About Kali Valuation
Our relative valuation model uses a comparative analysis of Kali. We calculate exposure to Kali's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Kali's related companies.Kali, Inc., doing business as Kali-Extracts, Inc., engages in the research and development of cannabis treatments for various illnesses, diseases, and chronic pain as a symptom of various diagnoses. The company was formerly known as VLOV Inc. and changed its name to Kali, Inc. in February 2016. KALI INC operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 171 people.
Kali Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Quarterly Earnings Growth Y O Y | 1.236 |
Additional Tools for Kali Stock Analysis
When running Kali's price analysis, check to measure Kali's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kali is operating at the current time. Most of Kali's value examination focuses on studying past and present price action to predict the probability of Kali's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kali's price. Additionally, you may evaluate how the addition of Kali to your portfolios can decrease your overall portfolio volatility.